Company intelligence / Profile preview

ExoDiscovery

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

ExoDiscovery is a South Korean biotechnology company specializing in the isolation and analysis of exosomes for diagnostic and therapeutic applications. The company utilizes its proprietary ExoCAS (Exosome Capture and Analysis System) platform, which employs magnetic beads and specific ligands to isolate high-purity exosomes from various biological fluids. This technology aims to overcome the limitations of traditional ultracentrifugation, providing a faster and more efficient method for liquid biopsy and biomarker discovery. Beyond diagnostics, ExoDiscovery is exploring the use of exosomes as drug delivery vehicles and therapeutic agents for cancer and inflammatory conditions.

Therapeutic areas: ImmunologyOncology
Modalities: Exosome-based therapyBiologicDiagnostic
Industry: Biotech

Beyond the preview

Go deeper on ExoDiscovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExoDiscovery.

Explore the full profile